Saudi Arabia
· Delayed Price · Currency is SAR Lana Medical Company Statistics
Total Valuation
Lana Medical Company has a market cap or net worth of SAR 140.40 million. The enterprise value is 145.32 million.
| Market Cap | 140.40M |
| Enterprise Value | 145.32M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Lana Medical Company has 3.60 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 3.60M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 56.80% |
| Owned by Institutions (%) | n/a |
| Float | 1.56M |
Valuation Ratios
The trailing PE ratio is 21.30.
| PE Ratio | 21.30 |
| Forward PE | n/a |
| PS Ratio | 2.87 |
| PB Ratio | 2.47 |
| P/TBV Ratio | 2.96 |
| P/FCF Ratio | 394.87 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.05, with an EV/FCF ratio of 408.70.
| EV / Earnings | 26.46 |
| EV / Sales | 3.56 |
| EV / EBITDA | 18.05 |
| EV / EBIT | 22.28 |
| EV / FCF | 408.70 |
Financial Position
The company has a current ratio of 5.56, with a Debt / Equity ratio of 0.17.
| Current Ratio | 5.56 |
| Quick Ratio | 4.59 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | 1.02 |
| Debt / FCF | 23.12 |
| Interest Coverage | 33.20 |
Financial Efficiency
Return on equity (ROE) is 12.34% and return on invested capital (ROIC) is 7.70%.
| Return on Equity (ROE) | 12.34% |
| Return on Assets (ROA) | 6.77% |
| Return on Capital (ROIC) | 7.70% |
| Revenue Per Employee | 187,156 |
| Profits Per Employee | 25,197 |
| Employee Count | 218 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 5.29 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 37.01 |
| 200-Day Moving Average | 37.41 |
| Relative Strength Index (RSI) | 62.00 |
| Average Volume (20 Days) | 3,978 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Lana Medical Company had revenue of SAR 40.80 million and earned 5.49 million in profits. Earnings per share was 1.83.
| Revenue | 40.80M |
| Gross Profit | 19.22M |
| Operating Income | 6.52M |
| Pretax Income | 6.62M |
| Net Income | 5.49M |
| EBITDA | 7.54M |
| EBIT | 6.52M |
| Earnings Per Share (EPS) | 1.83 |
Balance Sheet
The company has 3.30 million in cash and 8.22 million in debt, giving a net cash position of -4.92 million or -1.37 per share.
| Cash & Cash Equivalents | 3.30M |
| Total Debt | 8.22M |
| Net Cash | -4.92M |
| Net Cash Per Share | -1.37 |
| Equity (Book Value) | 47.42M |
| Book Value Per Share | 15.81 |
| Working Capital | 36.77M |
Cash Flow
In the last 12 months, operating cash flow was 5.45 million and capital expenditures -5.10 million, giving a free cash flow of 355,564.
| Operating Cash Flow | 5.45M |
| Capital Expenditures | -5.10M |
| Free Cash Flow | 355,564 |
| FCF Per Share | 0.10 |
Margins
Gross margin is 47.11%, with operating and profit margins of 15.99% and 13.46%.
| Gross Margin | 47.11% |
| Operating Margin | 15.99% |
| Pretax Margin | 16.23% |
| Profit Margin | 13.46% |
| EBITDA Margin | 18.47% |
| EBIT Margin | 15.99% |
| FCF Margin | 0.87% |
Dividends & Yields
Lana Medical Company does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 4.69% |
| FCF Yield | 0.25% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Lana Medical Company has an Altman Z-Score of 2.06. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.06 |
| Piotroski F-Score | n/a |